These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

679 related articles for article (PubMed ID: 26884601)

  • 1. TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway.
    Viel S; Marçais A; Guimaraes FS; Loftus R; Rabilloud J; Grau M; Degouve S; Djebali S; Sanlaville A; Charrier E; Bienvenu J; Marie JC; Caux C; Marvel J; Town L; Huntington ND; Bartholin L; Finlay D; Smyth MJ; Walzer T
    Sci Signal; 2016 Feb; 9(415):ra19. PubMed ID: 26884601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF-β and IL-15 Synergize through MAPK Pathways to Drive the Conversion of Human NK Cells to an Innate Lymphoid Cell 1-like Phenotype.
    Hawke LG; Mitchell BZ; Ormiston ML
    J Immunol; 2020 Jun; 204(12):3171-3181. PubMed ID: 32332109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blocking transforming growth factor-β signaling pathway augments antitumor effect of adoptive NK-92 cell therapy.
    Yang B; Liu H; Shi W; Wang Z; Sun S; Zhang G; Hu Y; Liu T; Jiao S
    Int Immunopharmacol; 2013 Oct; 17(2):198-204. PubMed ID: 23806302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells.
    Marçais A; Cherfils-Vicini J; Viant C; Degouve S; Viel S; Fenis A; Rabilloud J; Mayol K; Tavares A; Bienvenu J; Gangloff YG; Gilson E; Vivier E; Walzer T
    Nat Immunol; 2014 Aug; 15(8):749-757. PubMed ID: 24973821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of the effects of inhibitory cytokines on human natural killer cells and the mechanistic features of transforming growth factor-beta.
    Lee HM; Kim KS; Kim J
    Cell Immunol; 2014 Jul; 290(1):52-61. PubMed ID: 24879062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-15 activates mTOR and primes stress-activated gene expression leading to prolonged antitumor capacity of NK cells.
    Mao Y; van Hoef V; Zhang X; Wennerberg E; Lorent J; Witt K; Masvidal L; Liang S; Murray S; Larsson O; Kiessling R; Lundqvist A
    Blood; 2016 Sep; 128(11):1475-89. PubMed ID: 27465917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asiaticoside modulates human NK cell functional fate by mediating metabolic flexibility in the tumor microenvironment.
    Guo Y; Xu J; Jia Y; Tian Y; Zhang Y; Zhang J; Wang Y; Chen L
    Phytomedicine; 2024 Oct; 133():155921. PubMed ID: 39121533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine 5'-monophosphate-activated protein kinase regulates IL-10-mediated anti-inflammatory signaling pathways in macrophages.
    Zhu YP; Brown JR; Sag D; Zhang L; Suttles J
    J Immunol; 2015 Jan; 194(2):584-94. PubMed ID: 25512602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined immunogene therapy of IL-6 and IL-15 enhances anti-tumor activity through augmented NK cytotoxicity.
    Lin CY; Chuang TF; Liao KW; Huang YJ; Pai CC; Chu RM
    Cancer Lett; 2008 Dec; 272(2):285-95. PubMed ID: 18760876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Inverse Relationship Between c-Kit/CD117 and mTOR Confers NK Cell Dysregulation Late After Severe Injury.
    Bösken B; Hepner-Schefczyk M; Vonderhagen S; Dudda M; Flohé SB
    Front Immunol; 2020; 11():1200. PubMed ID: 32670280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human tumour immune evasion via TGF-β blocks NK cell activation but not survival allowing therapeutic restoration of anti-tumour activity.
    Wilson EB; El-Jawhari JJ; Neilson AL; Hall GD; Melcher AA; Meade JL; Cook GP
    PLoS One; 2011; 6(9):e22842. PubMed ID: 21909397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner.
    Ghiringhelli F; Ménard C; Terme M; Flament C; Taieb J; Chaput N; Puig PE; Novault S; Escudier B; Vivier E; Lecesne A; Robert C; Blay JY; Bernard J; Caillat-Zucman S; Freitas A; Tursz T; Wagner-Ballon O; Capron C; Vainchencker W; Martin F; Zitvogel L
    J Exp Med; 2005 Oct; 202(8):1075-85. PubMed ID: 16230475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pro- and antiinflammatory cytokine signaling: reciprocal antagonism regulates interferon-gamma production by human natural killer cells.
    Yu J; Wei M; Becknell B; Trotta R; Liu S; Boyd Z; Jaung MS; Blaser BW; Sun J; Benson DM; Mao H; Yokohama A; Bhatt D; Shen L; Davuluri R; Weinstein M; Marcucci G; Caligiuri MA
    Immunity; 2006 May; 24(5):575-90. PubMed ID: 16713975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An IL-15 superagonist/IL-15Rα fusion complex protects and rescues NK cell-cytotoxic function from TGF-β1-mediated immunosuppression.
    Fujii R; Jochems C; Tritsch SR; Wong HC; Schlom J; Hodge JW
    Cancer Immunol Immunother; 2018 Apr; 67(4):675-689. PubMed ID: 29392336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PDK1 orchestrates early NK cell development through induction of E4BP4 expression and maintenance of IL-15 responsiveness.
    Yang M; Li D; Chang Z; Yang Z; Tian Z; Dong Z
    J Exp Med; 2015 Feb; 212(2):253-65. PubMed ID: 25624444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role for transforming growth factor-beta 1 in regulating natural killer cell and T lymphocyte proliferative responses during acute infection with lymphocytic choriomeningitis virus.
    Su HC; Leite-Morris KA; Braun L; Biron CA
    J Immunol; 1991 Oct; 147(8):2717-27. PubMed ID: 1918986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
    Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M
    Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic IL-15 Stimulation and Impaired mTOR Signaling and Metabolism in Natural Killer Cells During Acute Myeloid Leukemia.
    Bou-Tayeh B; Laletin V; Salem N; Just-Landi S; Fares J; Leblanc R; Balzano M; Kerdiles YM; Bidaut G; Hérault O; Olive D; Aurrand-Lions M; Walzer T; Nunès JA; Fauriat C
    Front Immunol; 2021; 12():730970. PubMed ID: 34975835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mTOR Signaling pathway as a master regulator of memory CD8
    Rostamzadeh D; Yousefi M; Haghshenas MR; Ahmadi M; Dolati S; Babaloo Z
    J Cell Physiol; 2019 Aug; 234(8):12353-12368. PubMed ID: 30710341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NK cells are the crucial antitumor mediators when STAT3-mediated immunosuppression is blocked in hepatocellular carcinoma.
    Sui Q; Zhang J; Sun X; Zhang C; Han Q; Tian Z
    J Immunol; 2014 Aug; 193(4):2016-23. PubMed ID: 25015826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.